Terug
17
Ook genoteerd als
FGROY
OTC
Dagbereik
€ 2,50
€ 2,50
52-Weeksbereik
€ 2,00
€ 2,75
Volume
100
50D / 200D Gem.
€ 2,46
/
€ 2,60
Vorige Slotkoers
€ 2,50
Koershistorie
Financiële Trends
Sectorvergelijking
vs Industrials sector mediaan (890 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 10,7 | 14,4 |
| P/B | 2,0 | 1,9 |
| ROE % | 19,2 | 11,3 |
| Net Margin % | 2,7 | 6,5 |
| Rev Growth 5Y % | 28,0 | 8,4 |
| D/E | 1,9 | 0,6 |
Belangrijkste Punten
Revenue grew 27,96% annually over 5 years — strong growth
ROE of 19,17% — decent returns on equity
Generating 597,80M in free cash flow
P/E of 10,65 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,27%
Cash machine — converts 468,86% of earnings into free cash flow
Groei
Revenue Growth (5Y)
27,96%
Revenue (1Y)-1,31%
Earnings (1Y)N/A
FCF Growth (3Y)22,88%
Kwaliteit
Return on Equity
19,17%
ROIC8,17%
Net Margin2,74%
Op. Margin4,78%
Veiligheid
Debt / Equity
1,93
Current Ratio0,70
Interest Coverage3,59
Waardering
P/E Ratio
10,65
P/B Ratio1,95
EV/EBITDA11,38
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,31% | Revenue Growth (3Y) | 9,77% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 20,99% |
| Revenue Growth (5Y) | 27,96% | Earnings Growth (5Y) | 12,93% |
| Profitability | |||
| Revenue (TTM) | 4,65B | Net Income (TTM) | 127,50M |
| ROE | 19,17% | ROA | 3,48% |
| Gross Margin | 38,96% | Operating Margin | 4,78% |
| Net Margin | 2,74% | Free Cash Flow (TTM) | 597,80M |
| ROIC | 8,17% | FCF Growth (3Y) | 22,88% |
| Safety | |||
| Debt / Equity | 1,93 | Current Ratio | 0,70 |
| Interest Coverage | 3,59 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 10,65 | P/B Ratio | 1,95 |
| P/S Ratio | 0,29 | PEG Ratio | 0,00 |
| EV/EBITDA | 11,38 | Dividend Yield | 0,04% |
| Market Cap | 1,36B | Enterprise Value | 2,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,65B | 4,72B | 3,86B | 2,93B | 1,74B |
| Net Income | 127,50M | -15,90M | 87,10M | 636,40M | 78,40M |
| EPS (Diluted) | 0,21 | -0,02 | 0,10 | 0,60 | 0,01 |
| Gross Profit | 1,81B | 2,88B | 829,30M | 0,0 | -1,16B |
| Operating Income | 222,60M | 46,50M | 153,90M | 122,80M | 224,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,66B | 3,81B | 4,41B | 3,83B | 8,29B |
| Total Liabilities | 2,95B | 3,17B | 3,66B | 2,95B | 7,14B |
| Shareholders' Equity | 696,70M | 633,30M | 740,20M | 876,60M | 1,18B |
| Total Debt | 1,35B | 1,63B | 2,07B | 1,41B | 3,82B |
| Cash & Equivalents | 171,40M | 496,50M | 791,40M | 787,70M | 1,44B |
| Current Assets | 1,29B | 1,38B | 1,75B | 1,57B | 5,65B |
| Current Liabilities | 1,85B | 2,00B | 2,00B | 2,08B | 4,19B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#457 of 658
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026